https://www.marketscreener.com/quote/stock/GNI-GROUP-LTD-6814689/news/GNI-NMPA-has-approved-GNI-Group-s-Subsidiary-Cullgen-s-IND-for-TRK-Degrader-Clinical-Trial-41251672/?utm_source=telegram&utm_medium=social&utm_campaign=share